Nourish Shows 68% Six-Month GLP-1 Persistence, Outperforming Industry Benchmarks

Audio By Carbonatix

NEW YORK--(BUSINESS WIRE)--Mar 31, 2026--

Despite the promise of GLP-1s as an effective tool for weight loss, patient persistence on the medication is a barrier to long-term outcomes. Today, Nourish, the only dietitian-led metabolic health clinic in the country, released data showing that 68% of Nourish patients remained on GLP-1 therapy at six months, compared to a 46% industry benchmark. Full results are available in Nourish’s new whitepaper: GLP-1 Persistence through Dietitian-Led Care.

The Nourish GLP-1 Companion Care program pairs evidence-based nutrition therapy delivered by registered dietitians with wraparound physician support. Patients follow a structured clinical pathway and receive personalized nutrition support tailored to their individual needs, helping them achieve their treatment goals while mitigating side effects. This integrated approach is designed to maximize the efficacy and durability of GLP-1 treatment.

Nourish’s data demonstrates that embedding nutrition care directly into GLP-1 treatment improves persistence over time, which in turn helps patients build the sustainable habits that support long-term outcomes.

“We find many patients struggle to stay on GLP-1s long enough to see results due to side effects and lack of support,” said Aidan Dewar, co-founder and CEO of Nourish. “When patients receive personalized, dietitian-led care alongside GLP-1s, they’re better able to tolerate the medications, manage side effects, and ultimately build habits that lead to more durable outcomes.”

Nourish supports patients across the full GLP-1 journey:

• Nutrition-first care for patients not on medication
• Companion care alongside medication to improve persistence and manage side effects
• Off-ramp support to sustain outcomes after medication discontinuation

By pairing medication with ongoing nutrition care, Nourish helps patients stay on therapy longer and achieve better long-term outcomes, while enabling health plans and employers to maximize the value of their GLP-1 investment.

To learn more, read the full whitepaper: GLP-1 Persistence through Dietitian-Led Care.

About Nourish

Nourish is tackling America’s healthcare crisis by addressing the root cause of metabolic disease through insurance-covered, AI-powered virtual nutrition care. The company combines personalized visits with registered dietitians (RDs), labs, and an AI-native technology platform to deliver scalable, effective treatment for chronic conditions.

As the only dietitian-led metabolic health clinic in the country, Nourish makes it easy for patients to get matched to an expert provider, access care from home, and improve their health — typically at no cost. Through partnerships with all major insurers, as well as health systems and local providers, Nourish is available to hundreds of millions of patients across all 50 states. Nourish is actively hiring across clinical and business roles — learn more at usenourish.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260331727566/en/

Press contact:Britta Franson,[email protected]

KEYWORD: NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: VITAMINS/SUPPLEMENTS FITNESS & NUTRITION HEALTH TECHNOLOGY PRACTICE MANAGEMENT OTHER HEALTH BIOTECHNOLOGY MANAGED CARE GENERAL HEALTH PHARMACEUTICAL HEALTH

SOURCE: Nourish

Copyright Business Wire 2026.

PUB: 03/31/2026 10:00 AM/DISC: 03/31/2026 10:00 AM

http://www.businesswire.com/news/home/20260331727566/en